Cargando…

Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone

Direct oral anticoagulants (DOACs) are not recommended in COVID-19 patients receiving dexamethasone because of potential drug-drug and drug-disease interactions affecting anticoagulant concentration and activity. To evaluate short- and long-term pharmacokinetic interactions, serial through and peak...

Descripción completa

Detalles Bibliográficos
Autores principales:	Potere, Nicola, Candeloro, Matteo, Porreca, Ettore, Marinari, Stefano, Federici, Camilla, Auciello, Raffaella, Di Nisio, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425464/ https://www.ncbi.nlm.nih.gov/pubmed/34498156 http://dx.doi.org/10.1007/s11239-021-02561-w

Ejemplares similares

Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021)

Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing In Vitro Fertilization
por: Candeloro, Matteo, et al.
Publicado: (2020)

Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis
por: Potere, Nicola, et al.
Publicado: (2020)

Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
por: Potere, Nicola, et al.
Publicado: (2023)

Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19
por: Di Nisio, Marcello, et al.
Publicado: (2021)

Prognostic nutritional index in elderly patients hospitalized for acute heart failure
por: Candeloro, Matteo, et al.
Publicado: (2020)

Plasma concentrations of D-dimer and outcome of in vitro fertilization
por: Di Nisio, Marcello, et al.
Publicado: (2014)

Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux
por: Di Nisio, Marcello, et al.
Publicado: (2013)

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation
por: Potere, Nicola, et al.
Publicado: (2020)

Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review
por: Candeloro, Matteo, et al.
Publicado: (2023)

Serum or Plasma for Quantification of Direct Oral Anticoagulants?
por: Aakerøy, Rachel, et al.
Publicado: (2022)

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis
por: Porfidia, Angelo, et al.
Publicado: (2020)

Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort
por: Candeloro, Matteo, et al.
Publicado: (2022)

Global access to affordable direct oral anticoagulants
por: Neumann, Ignacio, et al.
Publicado: (2021)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism
por: Masini, Marta, et al.
Publicado: (2023)

Management of bleeding in patients treated with direct oral anticoagulants
por: Levi, Marcel
Publicado: (2016)

Emergency Cardiac Surgery in Patients on Direct Oral Anticoagulants
por: De Paulis, Stefano, et al.
Publicado: (2022)

Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system
por: Pfrepper, Christian, et al.
Publicado: (2020)

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
por: Candeloro, Matteo, et al.
Publicado: (2022)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation
por: Mumoli, Nicola, et al.
Publicado: (2021)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Direct oral anticoagulant: Review article
por: Nasiri, Abdulrahman, et al.
Publicado: (2022)

Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
por: Lucà, Fabiana, et al.
Publicado: (2023)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Prognostic role of different findings at echocardiography in acute pulmonary embolism: a critical review and meta-analysis
por: Cimini, Ludovica Anna, et al.
Publicado: (2023)

Use of direct oral anticoagulant in ischaemic heart disease: the COMPASS study
por: Ferri, Luca A, et al.
Publicado: (2019)

Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation
por: Piersma‐Wichers, Margriet, et al.
Publicado: (2021)

Drug interactions of direct oral anticoagulants in elderly patients with cardiometabolic diseases
por: Bellia, Alfonso, et al.
Publicado: (2021)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2ggii54loognthoq22e92o4vgt